Deriv Achieves Prestigious Platinum Accreditation by Investors In People

Deriv office celebrates Platinum accreditation by Investors in People (IIP).

Deriv employees during IIP-Platinum celebrations.

  • The accolade puts Deriv in the top 2% of global organisations accredited by Investors In People
  • Deriv ranks 5th in the finance and insurance sector for companies of a similar size

CYBERJAYA, Malaysia, Jan. 26, 2024 (GLOBE NEWSWIRE) — Deriv, one of the world’s largest online trading platforms, has been awarded Investors In People’s prestigious Platinum accreditation recognising its exemplary commitment to its people. This accolade places Deriv among the top 2% of global organisations accredited by Investors in People (IIP), firmly establishing it as a trailblazer for people practices.

IIP ranked Deriv 5th in the finance and insurance sector among companies of similar size and 127th among all accredited organisations. The Platinum accreditation substantiates Deriv’s consistent commitment to building an engaged, high-performing workforce as well as its first-rate organisational culture and people practices.

Seema Hallon, Chief Human Resource Officer at Deriv, expressed her delight over this achievement: “The Platinum IIP Accreditation is not just an accolade. It represents our promise to continue innovating, inspiring, and leading the way in people practices, while upholding the highest standards of excellence and employee empowerment. It also reinforces our absolute commitment to building a supportive workplace that lets employees bring their best game to work so they can thrive and grow with the company.”

Deriv started to use the IIP framework for benchmarking its people practices in 2022, earning Gold accreditation on its first assessment. In 2023, based on its performance against the Make Work Better framework, the company achieved Platinum accreditation.

Paul Devoy, CEO of Investors in People said of Deriv’s achievement, “This Platinum accreditation is not just a badge of honour but a testament to Deriv’s unwavering dedication to its core values of integrity, competence, teamwork, and customer focus, and, most importantly, its people.”

Devoy continued, “Deriv can proudly say it is in the top 2% of high-performing organisations worldwide that have been assessed against our rigorous standards for demonstrating sustainable success in empowering and including people. ”

For insights into the work culture and career opportunities at Deriv, visit our careers page.

About Deriv

For 25 years, Deriv has been committed to making online trading accessible to anyone, anywhere. Trusted by over 2.5 million traders worldwide, the company offers an expansive range of trade types and boasts over 200 assets across popular markets on its award-winning, intuitive trading platforms. With a workforce of more than 1,300 people globally, Deriv has cultivated an environment that celebrates achievements, encourages professional growth, and fosters talent development, which is reflected in its Platinum accreditation by Investors in People.


PRESS CONTACT

Aleksandra Zuzic
aleksandra@deriv.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/31ef8e93-558c-4ea6-ac0d-65e415c52b2d

GlobeNewswire Distribution ID 1000910540

KFSH&RC Celebrates 25 Scientists Named in Stanford’s Top 2% Most-Cited Researchers Worldwide

KFSH&RC Celebrates 25 Scientists Named in Stanford’s Top 2% Most-Cited Researchers Worldwide
Health

Highlight of the event honoring 25 scientists included in the Standford List from King Faisal Specialist Hospital and Research Centre

RIYADH, Saudi Arabia, Jan. 24, 2024 (GLOBE NEWSWIRE) — King Faisal Specialist Hospital and Research Centre honored 25 scientists who joined Stanford University’s prestigious list, marking them among the ‘top 2% most-cited scientists’ list updated in October 2023.

The recent release recognizes 25 distinguished KFSH&RC scientists, among the top 2% most-cited researchers worldwide in 2021-2022, and acknowledges their overall career accomplishments. This prestigious recognition celebrates the outstanding contributions and impact of KFSH&RC researchers on the global scientific stage, highlighting KFSH&RC’s steady commitment to advancing healthcare through novel research. It elevates its international reputation as a pioneer hub for innovative research.

His Excellency Dr. Majid Al Fayyadh, Chief Executive Officer, KFSH&RC, stated: “We are incredibly proud of this recognition, a testament to our firm commitment to advancing healthcare through cutting-edge research and innovation at home and beyond. This new milestone reflects the dedication and expertise of our exceptional team of scientists and medical professionals who continually push the boundaries of knowledge. At KFSH&RC, we remain dedicated to our mission to shape the future of healthcare and contribute to global advancements in the field.”

Renowned for its annual compilation, Stanford University highlights the remarkable achievements of scientists whose research has reaped the highest citations in international and scientific journals. The university unveils a list featuring 180,000 researchers representing the top 2% of most-cited scientists globally each year. This compilation covers 22 research fields and 176 subfields, utilizing citation metrics from the Scopus database.

KFSH&RC extends heartfelt congratulations to researchers recognized for the year 2021-2022. Each scientist left an indelible mark in various medical fields. Their contributions exemplify KFSH&RC’s commitment to excellence and leadership in healthcare innovation.

This recognition further enhances KFSH&RC’s reputation as a holistic healthcare hub, highlighting its dedication to building a resilient healthcare system through continuous research and advancement, in line with Vision 2030.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/11e5bca6-007a-405e-8eb7-ea79910ca705

Contact information:
kfshrc@mcsaatchi.com

GlobeNewswire Distribution ID 9023567

KFSH&RC Celebrates 25 Scientists Named in Stanford’s Top 2% Most-Cited Researchers Worldwide

KFSH&RC Celebrates 25 Scientists Named in Stanford’s Top 2% Most-Cited Researchers Worldwide
Health

Highlight of the event honoring 25 scientists included in the Standford List from King Faisal Specialist Hospital and Research Centre

RIYADH, Saudi Arabia, Jan. 24, 2024 (GLOBE NEWSWIRE) — King Faisal Specialist Hospital and Research Centre honored 25 scientists who joined Stanford University’s prestigious list, marking them among the ‘top 2% most-cited scientists’ list updated in October 2023.

The recent release recognizes 25 distinguished KFSH&RC scientists, among the top 2% most-cited researchers worldwide in 2021-2022, and acknowledges their overall career accomplishments. This prestigious recognition celebrates the outstanding contributions and impact of KFSH&RC researchers on the global scientific stage, highlighting KFSH&RC’s steady commitment to advancing healthcare through novel research. It elevates its international reputation as a pioneer hub for innovative research.

His Excellency Dr. Majid Al Fayyadh, Chief Executive Officer, KFSH&RC, stated: “We are incredibly proud of this recognition, a testament to our firm commitment to advancing healthcare through cutting-edge research and innovation at home and beyond. This new milestone reflects the dedication and expertise of our exceptional team of scientists and medical professionals who continually push the boundaries of knowledge. At KFSH&RC, we remain dedicated to our mission to shape the future of healthcare and contribute to global advancements in the field.”

Renowned for its annual compilation, Stanford University highlights the remarkable achievements of scientists whose research has reaped the highest citations in international and scientific journals. The university unveils a list featuring 180,000 researchers representing the top 2% of most-cited scientists globally each year. This compilation covers 22 research fields and 176 subfields, utilizing citation metrics from the Scopus database.

KFSH&RC extends heartfelt congratulations to researchers recognized for the year 2021-2022. Each scientist left an indelible mark in various medical fields. Their contributions exemplify KFSH&RC’s commitment to excellence and leadership in healthcare innovation.

This recognition further enhances KFSH&RC’s reputation as a holistic healthcare hub, highlighting its dedication to building a resilient healthcare system through continuous research and advancement, in line with Vision 2030.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/11e5bca6-007a-405e-8eb7-ea79910ca705

Contact information:
kfshrc@mcsaatchi.com

GlobeNewswire Distribution ID 9023567

‫”التخصصي” يكرّم 25 عالماً ضمن قائمة ستانفورد لـ 2% من العلماء الأعلى استشهاداً بأبحاثهم

جانب من تكريم 25 عالمًا من مستشفى الملك فيصل التخصصي ومركز الأبحاث ضمن قائمة ستانفورد
الصحة

جانب من تكريم 25 عالمًا من مستشفى الملك فيصل التخصصي ومركز الأبحاث ضمن قائمة ستانفور

الرياض, Jan. 24, 2024 (GLOBE NEWSWIRE) — كرّم مستشفى الملك فيصل التخصصي ومركز الأبحاث 25 من علمائه، صُنّفوا ضمن قائمة جامعة ستانفورد لـ ـ2% من العلماء والباحثين الأعلى استشهادًا بأبحاثهم المنشورة في مختلف التخصصات خلال العامين 2021-

2022، ما يعكس التزام المستشفى الثابت بتطوير الرعاية الصحية من خلال البحث والابتكار، ويرسخ من مكانته كمركز أبحاث رائد في قطاع الرعاية الصحية على المستويين المحلي والعالمي.

وبهذه المناسبة؛ صرح معالي الرئيس التنفيذي للمستشفى الدكتور ماجد الفياض قائلاً: “نحن فخورون للغاية بهذا التكريم الذي يعد دليلاً على التزامنا الراسخ بتعزيز الرعاية الصحية وتشكيل مستقبلها من خلال البحث والابتكار. وأكد معاليه أن الانجاز يعكس التفاني والخبرة الاستثنائية للعلماء والباحثين في التخصصي الذين يواصلون عملهم العلمي بلا كلل لتوسيع حدود المعرفة، وتسخيرها لخير البشرية.

وتُعرف جامعة ستانفورد الأمريكية بقائمتها السنوية التي تسلط الضوء من خلالها على إنجازات العلماء الذين حصدت أبحاثهم أعلى الاستشهادات في المجلات الدولية والعلمية، حيث تكشف الجامعة عن قائمة تضم 180 ألف باحث يمثلون أفضل 2% من العلماء في 22 مجالًا بحثيًا و176 حقلاً فرعيًا، باستخدام مقاييس الاقتباس من قاعدة بيانات Scopus.

وتُعد قوائم ستانفورد مؤشراً موثوقاً لقياس جودة المخرجات العلمية في المجالات الطبية والبحثية، وتحظى بتقدير عالٍ في الأوساط العلمية؛ حيث تعتمد على درجة الاستشهاد بشكل أساسي إضافة لمقاييس بحثية أخرى.

يُذكر أن مستشفى الملك فيصل التخصصي ومركز الأبحاث من بين الأبرز عالميًا في تقديم الرعاية الصحية التخصصية، ورائدًا في الابتكار، ومركزًا متقدمًا في البحوث والتعليم الطبي، كما يسعى لتطوير التقنيات الطبية، والارتقاء بمستوى الرعاية الصحية على مستوى العالم، وذلك بالشراكة مع كبرى المؤسسات المحلية والإقليمية والدولية لتحقيق خدمة عالمية المستوى في المجالات السريرية والبحثية والتعليمية.

https://www.globenewswire.com/NewsRoom/AttachmentNg/11e5bca6-007a-405e-8eb7-ea79910ca705/ar

Contact information:
kfshrc@mcsaatchi.com

GlobeNewswire Distribution ID 9023567

Annual Anaqua Data Report Finds 2023 Patent Grant Volume Holds Steady

Analysis of USPTO IP data indicates continued innovation among US-based and global companies

BOSTON, Jan. 23, 2024 (GLOBE NEWSWIRE) — Anaqua, the leading innovation and intellectual property (IP) management technology provider, today announced its annual analysis of USPTO data using its advanced AcclaimIP patent analytics software. The analysis found that patent grants grew nearly one-half of one percent to 348,774 in 2023, marking a slight increase compared to 347,408 patents in 2022 placing US grants above pre-2019 levels.

Most Innovative Companies

Samsung Electronics leads the most innovative companies list, calculated by the number of granted patents, with 10,043 US grants (an 8% increase from 2022) in technology areas like data indexing schemes, electronic advertising technology, electronics related to renewable energy generation, organic electric solid-state devices, and plural semiconductor manufacturing.

The other top five most innovative companies were IBM with 4,003 granted patents, Qualcomm with 3,852, Taiwan Semiconductor Manufacturing Company with 3,442 and LG Corp with 3,319 granted patents.

Most Innovative Countries

US-based companies led all countries for the total number of granted US patents at 162,557, an 18% increase from 2022, with companies in the APAC region continuing to be well represented in the top five list of countries with US-granted patents. According to the data, Japan is in second place (40,960), followed by China (28,979) and South Korea (24,073). In fifth place is Germany, the leading European country, with 13,905 grants.

Top Innovation Areas

The top technology fields based on the most granted patents include semiconductor technology for the second year in a row, followed by virtual reality (VR), 5G, artificial intelligence (AI) and software technology related to unauthorized user detection. The rest of the top ten list includes program control unit, medical related, wireless, chemicals and chemistry related (appearing for the first time in the top ten), and network security technologies.

In examining AI-related US grants, the top inventive areas include machine learning models, general neural network development, neural networks combination technology, neural networks for image and video recognition and neural network training using backpropagation processes. The top assignees who received US granted patents in AI in 2023 were IBM, Samsung Electronics, Alphabet, Microsoft, and Amazon.

Shayne Phillips, Director, Analytics Solutions, AcclaimIP, said, “Our annual patent report examining the USPTO’s data shows a resilience and a consistency amongst the inventive community and companies seeking to protect their innovations. The analysis points to continued global innovation despite economic uncertainty and volatility.”

“We are honored to support many of the most innovative companies across the globe develop and manage their intellectual property to make better, strategic decisions about their business,” said Bob Romeo, CEO of Anaqua. “Our AcclaimIP solution helps customers search over 150 million patents to analyze intellectual property (IP) to determine patentability and assess the competitive patent landscape, ultimately to translate powerful patent analytics into business success.”

Download Anaqua’s infographic to review the full data here. To learn more about Anaqua’s AcclaimIP solution, visit acclaimip.com

Methodology

The data for this report was analyzed by Anaqua’s patent search and analytics software tool AcclaimIP, leveraging public patent information from the USPTO. The metric used to determine innovative organizations is patent applications published and granted applications over a 12-month period between December 1, 2022 and November 30, 2023.

About Anaqua

Anaqua, Inc. is a premier provider of integrated intellectual property (IP) management technology solutions and services for corporations and law firms. Its IP management software solutions, AQX® and PATTSY WAVE®, both offer best practice workflows with big data analytics and tech-enabled services to create an intelligent environment designed to inform IP strategy, enable IP decision-making, and streamline IP operations, tailored to each segment’s need. Today, nearly half of the top 100 U.S. patent filers and global brands, as well as a growing number of law firms worldwide use Anaqua’s solutions. Over one million IP executives, attorneys, paralegals, administrators, and innovators use the platform for their IP management needs. The company’s global operations are headquartered in Boston, with offices across the U.S., Europe, Asia, and Australia. For additional information, please visit anaqua.com, or on Anaqua’s LinkedIn.

Company Contact:
Amanda Glagolev
Director, Communications
Anaqua
617-375-5808
aglagolev@anaqua.com

GlobeNewswire Distribution ID 9021959

Breaking Ground in Fragrance Innovation: Sensegen and Global Leader Unveil Dynamic Collaboration

Rancho Santa Margarita, Calif., Jan. 22, 2024 (GLOBE NEWSWIRE) — Sensegen, a pioneer in biotech-enabled fragrance solutions, announced a strategic collaboration with Takasago, a global leader in the flavor and fragrance industry. This creative and technical partnership marks a significant leap forward in fragrance creation powered by biotechnology innovation.

“The collaboration with Takasago stands as a shining example of creative synergy through biotechnology, a dynamic partnership poised to reenergize the field of fragrance ingredients,” said V.P. of Fragrance, Angélique Burke, at Sensegen. “At Sensegen, we believe in the transformative power of collaboration, and this venture with Takasago signifies our commitment to pushing the boundaries of innovation and crafting a vibrant, eco-responsible future for olfactory experiences.”

“We are pleased about the dynamic collaboration with Sensegen, as it marks a pivotal moment in the fragrance industry,” said Takasago’s Global Fragrance Division President, Paul Ireland. “Takasago’s rich fragrance expertise, combined with Sensegen’s innovative biotech solutions, heralds a new era for perfumery.”

Novelty Unleashed
Sensegen and Takasago are joining forces to yield a fusion of creativity and technical prowess, promising to redefine the landscape of olfactory experiences.

Sensegen has achieved a significant milestone by leading the way in biotech fragrance ingredient development, notably as the pioneering creator of a class of natural musk raw materials. This groundbreaking accomplishment underscores the importance of prioritizing musk in pursuing sustainable and innovative fragrance solutions.

The impetus behind crafting these sought-after scents was a commitment to expanding options in perfumery, moving beyond synthetic petroleum-based fragrances and traditional extracts.

Beyond Ingredients: A Multi-tiered Approach
Sensegen is a full-fledged fragrance house that goes beyond supplying specialty ingredients. The mission is to strive to replace fossil-fueled synthetics and resource-depleting ingredients. There is an increasing global market for natural fragrance, with an estimation at $3.3 billion in the year 2022, and is projected to reach a revised size of $8.5 billion by 2030, growing at a CAGR of 12.7% over the period 2022-2030, according to the Global Natural Fragrance Industry report by Reportlinker.com.

The collaboration showcases Sensegen’s multidimensional capabilities, contributing novel materials and know-how in creating biotech-enabled fragrances. It is a testament to Sensegen’s commitment to work toward a better and clean future with a robust Intellectual Property (I.P.) position. This solid foundation positions Sensegen as a biosolutions fragrance leader in shaping the future of sustainable and inventive fragrance solutions.

Competitive Price and Scale
Coupled with innovation, it also provides cost-effective, scalable solutions to brands seeking a more natural profile and market share opportunities. For example, in the cleaning industry, the global natural household cleaners market size was valued at USD 5,237 million in 2022, and it is anticipated to reach USD 12,886 Million by 2030 at a CAGR of 11.9%, according to Straights Research. Products that fall under the category of “natural household cleaners” are those that do not include any synthetic chemicals. It does not contain any artificial components in any form. Sensegen’s dedication to making eco-friendly options economically viable underscores a mission to democratize sustainable fragrances, enabling a broader reach for businesses committed to environmental responsibility.

R&D and Commercialization Capabilities
The use of biotechnological processes allows for innovation and novelty in fragrance creation. Manufacturers can explore a broader range of biomolecular compounds, leading to the development of unique and distinctive scents that set products apart in the market.

Sensegen’s prowess extends beyond research and development (R&D) to effectively commercialize biotech-enabled fragrance solutions—the seamless integration of R&D excellence with commercial viability positions Sensegen as a competitive fragrance house.

Ireland added, “This collaboration will yield positive outcomes for the fragrance industry and offers transformative possibilities for brands exploring alternatives to virgin fossil-based ingredients. It’s an exciting journey, and we’re contributing our expertise to shape the olfactory landscape for many important industries.”

Consumer Trend for Naturalness
As consumers become more environmentally conscious, brands incorporating fragrance biomolecules can benefit from a positive perception associated with sustainability and responsible sourcing. In a 2023 market report, 44% of consumers globally agree to actively look for sustainability claims on multiple forms of detergent products/brands. This can contribute to brand loyalty and attract environmentally conscious consumers.

Sensegen will present at the American Cleaning Institute (ACI) Annual Meeting and Industry Convention, Jan 29-31, where Burke will speak on “Biotechnology has the potential to enhance fragrance creation and accelerate the promise of moving beyond fossil fuel-based synthetic materials.” Wed. Jan. 31 at 10 am. The presentation will be at the Innovation Showcase 2. The cleaning industry is intensifying its focus on making industry norms, prioritizing eco-friendly materials, reducing harmful chemicals, and adopting biodegradable solutions, reusable cloths, and energy efficiency.

About Sensegen
Sensegen® is at the forefront of fragrance innovation, pushing the boundaries of biotech-enabled solutions to create sustainable and captivating olfactory experiences. For more information, visit sensegen.com.

As a division of Blue California Ingredients, our innovative taste, smell, and beauty creative center is dedicated to delivering plant-based, natural, and sustainable solutions. Sensegen’s creators collaborate with advanced bio-techniques and team up to provide unique consumer-validated formulations.

Attachments

Ana Capretz, Head of Public Relations and Communications
Sensegen
+1.949.635.1991
ana.capretz@sensegen.com

GlobeNewswire Distribution ID 9022066